The National Institute of Diabetes & Digestive & Kidney Diseases

NIDDK Home > About NIDDK > Organization > Divisions > DDN

Clinical Obesity Research Panel (CORP)

• Background
• Roster
• Contact
• Reports

Background

The NIDDK Clinical Obesity Research Panel (CORP) is the successor to the National Task Force on Prevention and Treatment of Obesity, which was in existence from June 1991 until June 2003. The NIDDK CORP, composed of leading obesity researchers and clinicians, is charged with providing advice to the NIDDK Advisory Council on important clinical research needs related to obesity prevention and treatment, including their relative priority and costs, and identifies concepts for future clinical studies of obesity. The CORP serves in an advisory capacity to the Weight-control Information Network and may suggest topics for NIDDK-sponsored workshops and develop papers on topics related to clinical aspects of obesity. The CORP is placed organizationally under the auspices of the NIDDK Advisory Council and a member of the NIDDK Advisory Council serves on the CORP as a liaison member.

Roster

Steven N. Blair, PED Director of Epidemiology Cooper Institute 12330 Preston Road Dallas, TX 75230 Robert H. Eckel, MD Department of Medicine University of Colorado Health Sciences Center 4200 E 9th Avenue Denver, CO 80262 Samuel Klein, M.D. Professor of Medicine and Nutritional Science Director, Center for Human Nutrition Washington University School of Medicine 660 S. Euclid Avenue Campus Box 8031 St. Louis, MO 63110 Shiriki K. Kumanyika, Ph.D. Center for Clinical Epidemiology & Biostatistics University of Pennsylvania School of Medicine 8th Floor Blockley Hall 432 Guardian Drive Philadelphia, PA 19104-6021 Rudolph L. Leibel, M.D. Professor of Pediatrics and Medicine Head Division of Molecular Genetics Columbia University College of Physicians And Surgeons , Box 10 Russ Berrie Medical Science Pavilion 1150 Nicholas Avenue New York, NY 10032

Walter J. Pories, M.D. Professor of Surgery & Biochemistry Department of Surgery East Carolina University Greenville, NC 27858-4354 Nico Pronk, Ph.D., FACSM, FAWHP Vice President, Center for Health Promotion Research Investigator, HealthPartners Research Foundation HealthPartners 8100 34th Avenue South P.O. Box 1309 Minneapolis, MN 55440-1309 Delia Smith West, PhD Professor, Health Behavior College of Public Health 4301 West Markham St, #820 Little Rock, AR 72205 Rena R. Wing, Ph.D. Brown University Rise Building Miriam Hospital 164 Summit Avenue Providence, RI 02906

[Top]

Contact

For more information, please contact the Executive Director of the CORP, Dr. Susan Yanovski.

Reports

• Very Low-Calorie Diets
  Objective: To provide an overview of the published scientific information on the safety and efficacy of very low-calorie diets (VLCDs) and to provide rational recommendations for their use.
  JAMA. 1993;270:967-974.
  Reprints available from: Weight-control Information Network
• Weight Cycling
  Objective: To address concerns about the effects of weight cycling and to provide guidance on the risk-to-benefit ratio of attempts at weight loss, given current scientific knowledge.
  JAMA, 1994;272:1196-1202.
  Reprints available from: Weight-control Information Network
• Towards Prevention of Obesity: Research Directions
  Objective: The research initiatives and future directions presented in this paper were developed by The National Task Force on Prevention and Treatment of Obesity, appointed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. Five conceptual goals for obesity research were formulated for translation into action over the long term. These goals reflect a developing convergence of ideas from diverse sectors of the obesity research community and provide the overall direction for future research emphases.
  Obesity Research, 1994;6:571-584.
  Reprints available from: Weight-control Information Network
• Long-term Pharmacotherapy in the Management of Obesity
  Objective: To examine the rationale for long-term use of medications in the management of obesity, to provide an overview of published scientific information on their safety and efficacy, and to provide guidance to patients and practitioners regarding risks and benefits of treatment.
  JAMA, 1996;276:1907-1915.
  Reprints available from: Weight-control Information Network

[Top]